Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 17.4B | 15.9B | 15.7B | 16.1B |
| Cost of revenue | 12.5B | 11.7B | 11.9B | 11.9B |
| Gross profit | 4.9B | 4.1B | 3.8B | 4.2B |
| Operating expense | ||||
| Research & development | 499M | 541M | 506M | 524M |
| Selling general and admin | 2.5B | 2.6B | 2.5B | 2.6B |
| Other operating expenses | 658M | -750M | 885M | 956M |
| Operating income | 1.5B | 1.0B | 222M | 474M |
| Non operating interest income | ||||
| Income | 90M | 328M | 80M | 91M |
| Expense | 218M | 360M | 236M | 239M |
| Other income expense | — | — | — | — |
| Pretax income | 1.0B | -671M | 570M | 398M |
| Tax provision | 210M | 99M | 227M | -72M |
| Net income | 837M | -770M | 343M | 470M |
| Basic EPS | 0.9 | — | 0.3 | 0.5 |
| Diluted EPS | 0.9 | — | 0.3 | 0.5 |
| Basic average shares | 892.5M | — | 892.5M | 892.5M |
| Diluted average shares | 892.5M | — | 892.5M | 892.5M |
| EBITDA | 2.2B | 1.3B | 1.8B | 1.7B |
| Net income from continuing op. | 808M | -786M | 287M | 430M |
| Minority interests | -29M | -16M | -56M | -40M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |